Cerebral ergotism under treatment with ergotamine and ritonavir

Neurology

Volumn 57, Issue 4, 2001, Pages 743-744

  Spiegel, M ^a   Schmidauer, C ^a   Kampfl, A ^a   Sarcletti, M ^a   Poewe, W ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOTAMINE; RITONAVIR;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CASE REPORT; CEREBROVASCULAR DISEASE; DRUG METABOLISM; DRUG SAFETY; ERGOTISM; FEMALE; HEADACHE; HUMAN; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL;

EID: 0035964151     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.4.743     Document Type: Article

References (6)

1. Cytochrome P450 mediated metabolism of the HIV-1 protease inhibitor ritonavir in human liver microsomes
2. Ergotismus mit zerebralen Komplikationen
3. Ischaemic peripheral neuritis secondary to ergotism associated with ritonavir therapy
4. Severe ergotism associated with interaction between ritonavir and ergotamine
5. Leg ischaemia in a patient receiving ritonavir and ergotamine
6. Ergotism related to a single dose of ergotamine tartrate in an AIDS patient treated with ritonavir